LungLife AI Company

LungLife AI is a molecular diagnostics company that involves in the early detection and treatment of cancer.

Last Funding Type: Series B
Funding Status: IPO
Headquarters: Thousand Oaks, California, United States
Founded Date: 2006-01-01
Last Funding Date: 2015-06-17
Total Funding: 45825885
Technology: ['BioTech & HealthTech']
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Investors Number: 3
Industry: Medical BioTech